Allgood V - Search Results

1

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH. Herbst RS, et al. Among authors: allgood v. Clin Cancer Res. 2003 Sep 15;9(11):4108-15. Clin Cancer Res. 2003. PMID: 14519633 Clinical Trial.

2

Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer.

Herbst RS, Madden TL, Tran HT, Blumenschein GR Jr, Meyers CA, Seabrooke LF, Khuri FR, Puduvalli VK, Allgood V, Fritsche HA Jr, Hinton L, Newman RA, Crane EA, Fossella FV, Dordal M, Goodin T, Hong WK. Herbst RS, et al. Among authors: allgood v. J Clin Oncol. 2002 Nov 15;20(22):4440-7. doi: 10.1200/JCO.2002.04.006. J Clin Oncol. 2002. PMID: 12431966 Clinical Trial.

3

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours.

Mahalingam D, Wilding G, Denmeade S, Sarantopoulas J, Cosgrove D, Cetnar J, Azad N, Bruce J, Kurman M, Allgood VE, Carducci M. Mahalingam D, et al. Among authors: allgood ve. Br J Cancer. 2016 Apr 26;114(9):986-94. doi: 10.1038/bjc.2016.72. Br J Cancer. 2016. PMID: 27115568 Free PMC article. Clinical Trial.

4

Molecular mechanisms in cancer: what should clinicians know?

Ajani J, Allgood V. Ajani J, et al. Among authors: allgood v. Semin Oncol. 2005 Dec;32(6 Suppl 8):2-4. doi: 10.1053/j.seminoncol.2005.07.016. Semin Oncol. 2005. PMID: 16360003 Review.

5

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.

Mahalingam D, Peguero J, Cen P, Arora SP, Sarantopoulos J, Rowe J, Allgood V, Tubb B, Campos L. Mahalingam D, et al. Among authors: allgood v. Cancers (Basel). 2019 Jun 17;11(6):833. doi: 10.3390/cancers11060833. Cancers (Basel). 2019. PMID: 31212948 Free PMC article.

6

Multiple signaling pathways activate the chicken progesterone receptor.

Zhang Y, Bai W, Allgood VE, Weigel NL. Zhang Y, et al. Among authors: allgood ve. Mol Endocrinol. 1994 May;8(5):577-84. doi: 10.1210/mend.8.5.8058067. Mol Endocrinol. 1994. PMID: 8058067

7

Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer.

Allgood VE, Zhang Y, O'Malley BW, Weigel NL. Allgood VE, et al. Biochemistry. 1997 Jan 7;36(1):224-32. doi: 10.1021/bi961125c. Biochemistry. 1997. PMID: 8993337

8

Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation.

Bai W, Rowan BG, Allgood VE, O'Malley BW, Weigel NL. Bai W, et al. Among authors: allgood ve. J Biol Chem. 1997 Apr 18;272(16):10457-63. doi: 10.1074/jbc.272.16.10457. J Biol Chem. 1997. PMID: 9099688 Free article.

9

Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily.

Allgood VE, Cidlowski JA. Allgood VE, et al. J Biol Chem. 1992 Feb 25;267(6):3819-24. J Biol Chem. 1992. PMID: 1310983 Free article.

10

The influence of vitamin B6 on the structure and function of the glucocorticoid receptor.

Allgood VE, Powell-Oliver FE, Cidlowski JA. Allgood VE, et al. Ann N Y Acad Sci. 1990;585:452-65. doi: 10.1111/j.1749-6632.1990.tb28076.x. Ann N Y Acad Sci. 1990. PMID: 2192624 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters